Traders purchased shares of UnitedHealth Group Inc. (NYSE:UNH) on weakness during trading on Thursday. $126.18 million flowed into the stock on the tick-up and $107.82 million flowed out of the stock on the tick-down, for a money net flow of $18.36 million into the stock. Of all equities tracked, UnitedHealth Group had the 24th highest net in-flow for the day. UnitedHealth Group traded down ($1.58) for the day and closed at $140.80

Several brokerages have recently issued reports on UNH. Leerink Swann reaffirmed an “outperform” rating and issued a $150.00 target price on shares of UnitedHealth Group in a report on Tuesday, April 19th. Credit Suisse Group AG reaffirmed a “buy” rating on shares of UnitedHealth Group in a report on Wednesday, May 18th. Mizuho lifted their target price on UnitedHealth Group from $150.00 to $156.00 and gave the stock a “buy” rating in a report on Wednesday, April 20th. FBR & Co reiterated an “outperform” rating on shares of UnitedHealth Group in a research report on Thursday, March 17th. Finally, Morgan Stanley reiterated a “buy” rating on shares of UnitedHealth Group in a research report on Wednesday, May 18th. Two analysts have rated the stock with a hold rating, twenty-one have issued a buy rating and one has given a strong buy rating to the company. UnitedHealth Group currently has an average rating of “Buy” and a consensus target price of $146.02.

The stock has a 50-day moving average price of $137.53 and a 200 day moving average price of $126.17. The firm has a market cap of $134.32 billion and a price-to-earnings ratio of 22.71.

UnitedHealth Group (NYSE:UNH) last announced its quarterly earnings results on Tuesday, April 19th. The healthcare conglomerate reported $1.81 earnings per share (EPS) for the quarter, topping the Zacks’ consensus estimate of $1.72 by $0.09. During the same quarter in the prior year, the business earned $1.46 EPS. The firm had revenue of $44.50 billion for the quarter, compared to analyst estimates of $43.96 billion. The firm’s quarterly revenue was up 24.5% on a year-over-year basis. On average, analysts anticipate that UnitedHealth Group Inc. will post $7.89 EPS for the current year.

The business also recently disclosed a quarterly dividend, which was paid on Tuesday, June 28th. Investors of record on Friday, June 17th were given a dividend of $0.625 per share. The ex-dividend date of this dividend was Wednesday, June 15th. This is a positive change from UnitedHealth Group’s previous quarterly dividend of $0.50. This represents a $2.50 dividend on an annualized basis and a dividend yield of 1.77%.

In related news, Director William C. Ballard, Jr. sold 5,000 shares of the stock in a transaction that occurred on Thursday, June 16th. The shares were sold at an average price of $138.58, for a total transaction of $692,900.00. Following the completion of the transaction, the director now owns 72,229 shares of the company’s stock, valued at approximately $10,009,494.82. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is accessible through the SEC website. Also, Director Gail R. Wilensky sold 5,500 shares of the stock in a transaction that occurred on Friday, June 10th. The stock was sold at an average price of $139.80, for a total transaction of $768,900.00. Following the transaction, the director now directly owns 59,019 shares of the company’s stock, valued at approximately $8,250,856.20. The disclosure for this sale can be found here.

Other institutional investors recently bought and sold shares of the company. Penobscot Investment Management Company Inc. boosted its position in UnitedHealth Group by 52.5% in the fourth quarter. Penobscot Investment Management Company Inc. now owns 8,603 shares of the healthcare conglomerate’s stock worth $1,012,000 after buying an additional 2,960 shares during the last quarter. Fiduciary Trust Co. boosted its position in UnitedHealth Group by 4.6% in the fourth quarter. Fiduciary Trust Co. now owns 8,766 shares of the healthcare conglomerate’s stock worth $1,031,000 after buying an additional 384 shares during the last quarter. Bradley Foster & Sargent Inc. CT boosted its position in UnitedHealth Group by 24.8% in the fourth quarter. Bradley Foster & Sargent Inc. CT now owns 9,052 shares of the healthcare conglomerate’s stock worth $1,065,000 after buying an additional 1,800 shares during the last quarter. Chicago Equity Partners LLC boosted its position in UnitedHealth Group by 19.9% in the fourth quarter. Chicago Equity Partners LLC now owns 9,135 shares of the healthcare conglomerate’s stock worth $1,075,000 after buying an additional 1,515 shares during the last quarter. Finally, Checchi Capital Advisers LLC boosted its position in UnitedHealth Group by 32.9% in the fourth quarter. Checchi Capital Advisers LLC now owns 9,155 shares of the healthcare conglomerate’s stock worth $1,077,000 after buying an additional 2,267 shares during the last quarter.

UnitedHealth Group Incorporated is a diversified healthcare company. The Company operates through four segments: UnitedHealthcare, OptumHealth, OptumInsight and OptumRx. The Company conducts its operations through two business platforms: health benefits operating under UnitedHealthcare and health services operating under Optum.

Get Analysts' Upgrades and Downgrades Daily - Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.